MinorXanthine oxidase inhibitors×Testosterone 5α-reductase types 1 and 2 inhibitors
Updated · Methodology
Mechanism
Xanthine oxidase and aldehyde oxidase convert allopurinol into its active metabolite oxipurinol, which the kidneys excrete. Allopurinol is barely bound to plasma proteins (allopurinol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Dutasteride is metabolised in the liver by CYP3A4 and CYP3A5 and is excreted mainly in the faeces as metabolites (dutasteride SmPC, AEMPS). The allopurinol documents do not describe it as a CYP3A4 inhibitor or inducer, and dutasteride is not on the lists of drugs that interact with allopurinol (allopurinol SmPC, AEMPS, and allopurinol label, US Food and Drug Administration, FDA). The dutasteride documents do not mention allopurinol or other gout medicines either (dutasteride SmPC, AEMPS, and Avodart label, FDA).
Symptoms
The documents describe no symptoms of this combination. A common adverse effect of allopurinol is skin rash, while severe skin reactions and liver injury are rare (allopurinol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The most common adverse effects of dutasteride are impotence, decreased libido, ejaculation disorders and breast disorders (dutasteride SmPC, AEMPS).
Management
According to the documents, the combination is acceptable, and the doses of allopurinol and dutasteride need no change. No document names the pair (allopurinol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, and allopurinol label, US Food and Drug Administration, FDA; dutasteride SmPC, AEMPS, and Avodart label, FDA). Stop allopurinol immediately at the first sign of rash or any other sign of hypersensitivity (allopurinol SmPC, AEMPS). If anorexia, weight loss or itching develop during allopurinol treatment, check liver enzymes. In pre-existing liver disease, monitor them periodically, and stop allopurinol if liver enzymes are raised (allopurinol label, FDA). Dutasteride is contraindicated in severe hepatic impairment and is used with caution in mild to moderate hepatic impairment, where higher dutasteride levels are expected (dutasteride SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Allopurinol tablet (Dr. Reddy's Laboratories Limited) – Prescribing Information (2018)– ; DailyMed setid 19a138b8-d225-03e6-f762-abe71560204b
- AEMPS: Ficha técnica Zyloric 100 mg (alopurinol) (2026)– AEMPS CIMA, Zyloric 100 mg comprimidos, nº registro 43775, secciones 4.3, 4.4 y 4.5
- AEMPS: Ficha técnica: Dutasterida, Avidart 0,5 mg (nº registro 65178), sección 4.5 (2026)– AEMPS, CIMA, nº registro 65178 (Avidart 0,5 mg cápsulas blandas, GlaxoSmithKline), revisión 05/2026, secciones 4.5, 4.8 y 4.9
- FDA: AVODART (dutasteride) prescribing information (2025)– FDA, DailyMed setid 960797b3-09b1-4d6a-8ece-8b5d918e93e4 (Waylis Therapeutics), revisión 03/2025 (versión 4), secciones 7.1, 7.3, 10 y 12.3